Tremor characteristics differentially respond to levodopa and subthalamic nucleus deep brain stimulation in Parkinson’s disease
Objective: To identify factors predictive of responsiveness of tremor to levodopa and STN-DBS. Background: Tremor in Parkinson’s disease (PD) is phenotypically variable and has an…Anti-glutamic acid decarboxylase associated encephalitis presenting with new onset movement disorder after COVID-19 infection
Objective: To describe the unusual clinical manifestations in a patient with coronavirus disease 2019 (COVID-19). Background: Movement disorders are uncommon neurological manifestations of severe acute…‘That dark place’ – A thematic exploration of why people with Parkinson’s living in the UK, may, at times, experience suicidal ideation, as conveyed through an internet Forum
Objective: This study aims to understand what may lead a person with Parkinson’s (PwP) to experience suicidal thoughts. Better knowledge on the subject could lead…The effects of one session of dry needling on vital capacity in people with Parkinson’s Disease
Objective: The present study aimed to explore the effects of a single session of bilateral DN to the trapezius muscles trigger points on chest expansion and…Beyond Parkinson´s disease and synucleinopathies: unexpected identification of prodromal corticobasal syndrome by the updated MDS research criteria for prodromal PD
Objective: The aim of the current study was to determine the proportion of patients, initially classified as having prodromal Parkinson’s disease (pPD), phenoconverted to manifest…Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism
Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD) and vascular parkinsonism (VP)…Genome Wide Association Studies using TRACTOR reveals new associated loci with Parkinson Disease in a Latino Cohort
Objective: Our objective was using TRACTOR[1], which performs Genome Wide Association Study (GWAS) including Local Ancestry (LA) information, in Parkinson Disease (PD) using data from…How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial
Objective: To provide guidance on dosing of IPX203 based on clinical trial experience. Background: IPX203 is an extended-release, oral carbidopa-levodopa (CD-LD) formulation designed to rapidly…Long duration response to levodopa in advanced Parkinson disease
Objective: In patients with advanced Parkinson disease, it is possible to obtain a response to duodopa, if the dose is adjusted appropriately, even taking periods…Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson’s disease – a 7 Tesla functional MRS study
Objective: To investigate alterations of glutamate metabolism in the occipital cortex during visual processing in patients with Parkinson’s disease (PD). Background: Cognitive decline is a…
- « Previous Page
- 1
- …
- 195
- 196
- 197
- 198
- 199
- …
- 1554
- Next Page »